Switching From Prasugrel to Clopidogrel Navigating in Unknown Waters

被引：8
|
作者：
Angiolillo, Dominick J. [1 ]
Rollini, Fabiana [1 ]
机构：
[1] Univ Florida, Coll Med Jacksonville, Jacksonville, FL 32209 USA
来源：
JACC-CARDIOVASCULAR INTERVENTIONS | 2013年 / 6卷 / 02期
关键词：
P2Y(12) receptor antagonist; platelet reactivity; switch; ACUTE CORONARY SYNDROMES; ANTIPLATELET THERAPY; DIRECTIONS;
D O I：
10.1016/j.jcin.2012.12.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：166 / 168
页数：3
相关论文
共 50 条
  • [21] Switching from ticagrelor to prasugrel: A warning
    Parodi, Guido
    Bellandi, Benedetta
    Antoniucci, David
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 176 (03) : 1089 - 1090
  • [22] A comparison of the metabolism of clopidogrel and prasugrel
    Laizure, S. Casey
    Parker, Robert B.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2010, 6 (11) : 1417 - 1424
  • [23] Effectiveness of switching hyper responders from prasugrel to clopidogrel after acute coronary syndrome: the POBA SWITCH study
    Deharo, P.
    Pons, C.
    Quilici, J.
    Bonnet, G.
    Morange, P. E.
    Bonnet, J. L.
    Alessi, M. C.
    Cuisset, T.
    EUROPEAN HEART JOURNAL, 2013, 34 : 892 - 892
  • [24] Switching directly to prasugrel from clopidogrel results in greater inhibition of platelet aggregation in aspirin-treated subjects
    Payne, Christopher D.
    Li, Ying G.
    Brandt, John T.
    Jakubowski, Joseph A.
    Small, David S.
    Farid, Nagy A.
    Salazar, Daniel E.
    Winters, Kenneth J.
    PLATELETS, 2008, 19 (04) : 275 - 281
  • [25] Economic outcomes with prasugrel versus clopidogrel in acute coronary syndrome patients: observations from prasugrel users and matched clopidogrel users
    Olson, William H.
    Ma, Yi-Wen
    Crivera, Concetta
    Schein, Jeff
    Lefebvre, Patrick
    Laliberte, Francois
    Dea, Katherine
    Germain, Guillaume
    Lynch, Scott M.
    JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (12) : 1074 - 1084
  • [26] Time course of the antiplatelet effect after switching to clopidogrel from initial prasugrel therapy in patients with acute coronary syndrome
    Erito Furuse
    Hitoshi Takano
    Takeshi Yamamoto
    Yoshiaki Kubota
    Takashi Yoshizane
    Mitsunobu Kitamura
    Hideki Miyachi
    Yusuke Hosokawa
    Wataru Shimizu
    Heart and Vessels, 2017, 32 : 1432 - 1438
  • [27] Time course of the antiplatelet effect after switching to clopidogrel from initial prasugrel therapy in patients with acute coronary syndrome
    Furuse, Erito
    Takano, Hitoshi
    Yamamoto, Takeshi
    Kubota, Yoshiaki
    Yoshizane, Takashi
    Kitamura, Mitsunobu
    Miyachi, Hideki
    Hosokawa, Yusuke
    Shimizu, Wataru
    HEART AND VESSELS, 2017, 32 (12) : 1432 - 1438
  • [28] Decrease in high on-treatment platelet reactivity (HPR) prevalence on switching from clopidogrel to prasugrel: Insights from the switching anti-platelet (SWAP) study
    Saucedo, Jorge F.
    Angiolillo, Dominick J.
    DeRaad, Roger
    Frelinger, Andrew L., III
    Gurbel, Paul A.
    Costigan, Timothy M.
    Jakubowski, Joseph A.
    Ojeh, Clement K.
    Duvvuru, Suman
    Effron, Mark B.
    THROMBOSIS AND HAEMOSTASIS, 2013, 109 (02) : 347 - 355
  • [29] Impact of diabetes mellitus on the pharmacodynamic effects of prasugrel and ticagrelor after switching from clopidogrel in patients with coronary artery disease
    Galli, Mattia
    Rollini, Fabiana
    Been, Latonya
    Zenni, Martin M.
    Angiolillo, Dominick J.
    Franchi, Francesco
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 54 (03) : 461 - 469
  • [30] VerifyNow in DIabetes high-on-treatment platelet reactivity: a pharmacodynamic study on switching from clopidogrel to prasugrel (VERDI study)
    Cubero Gomez, Jose Maria
    Acosta Martinez, Juan
    Mendias Benitez, Cristina
    Diaz de la Llera, Luis
    Fernandez-Quero, Monica
    Guisado Rasco, Agustin
    Villa Gil-Ortega, Manuel
    Sanchez Gonzalez, Angel
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B146 - B146
12345